Form D · Biotechnology
NEOPROBE CORP
Dublin, OH · CIK 0000810509
Offering snapshot reported Jul 7, 2010 · SEC filing
- Reported sold
- $14M Offering amount: $14M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Jun 22, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2010 | Initial | $14,000,000 | No comparison | 3 | SEC filing |
| Jan 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144508
Source: Form D, filed Jul 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carl J. Aschinger, Jr. | Director |
| Reuven Avital | Director |
| Anthony K. Blair | Executive |
| Kirby I. Bland | Director |
| Rodger A. Brown | Executive |
| David C. Bupp | Director, Executive |
| Frederick O. Cope | Executive |
| Owen E. Johnson | Director |
| Brent L. Larson | Executive |
| Fred B. Miller | Director |
| Douglas L. Rash | Executive |
| Gordon A. Troup | Director |
| J. Frank Whitley, Jr. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
425 Metro Place North Suite 300
Dublin, OH, 43017
Dublin, OH, 43017